Polynucleotide Self-Assembly into Nanoparticles

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Polynucleotides are prone to degradation when stored outside cells due to the lack of protective intracellular materials, necessitating a method to stabilize and control their size for efficient storage and transfection.

Innovation Solution

The method involves chemically synthesizing or enzymatically synthesizing polynucleotides using modified nucleotides, which self-assemble into nanoparticles with controlled size and structure through interactions between modified nucleotides, allowing for stable storage and enhanced transfection efficiency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If polynucleotides are stored outside cells without protective materials, then storage is simple and accessible, but the polynucleotides are prone to degradation and damage

Engineering Contradiction:
Improvestorage simplicityVSAvoidpolynucleotide stability
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The polynucleotides perform self-packing by forming compact structures through intramolecular interactions, enabling them to protect themselves from environmental damage without requiring external protective materials or complex storage conditions

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The polynucleotides undergo structural transformation from extended conformations to compact packed structures, changing their physical parameters to achieve stability and resistance against degradation in extracellular environments

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If polynucleotide size is not controlled, then synthesis is simpler, but transfection efficiency and intracellular delivery are reduced

Engineering Contradiction:
Improvesynthesis simplicityVSAvoidtransfection efficiency
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The polynucleotides autonomously form compact structures of appropriate size through self-packing mechanisms, eliminating the need for complex external size control procedures while achieving optimal dimensions for cellular uptake and transfection

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The polynucleotides organize into discrete compact structures with defined size ranges, creating uniform particles that are optimized for intracellular delivery and transfection processes

Inventive Principle:
Principle #1Segmentation

3Reliability

If polynucleotides are packed into compact structures, then stability and transfection efficiency improve, but the packing process complexity increases

Engineering Contradiction:
Improvepolynucleotide stabilityVSAvoidpacking process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The polynucleotides spontaneously undergo self-packing to form compact structures driven by intrinsic molecular interactions, eliminating the need for complex external packing equipment or multi-step processing procedures

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The packing process replaces mechanical or chemical intervention with molecular-level self-organization driven by intramolecular forces, achieving compact structure formation without external mechanical compression or chemical crosslinking

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables stable storage of polynucleotides and increases their intracellular delivery efficiency by forming compact, uniformly sized nanoparticles that can pass through cell membranes without the need for transfection reagents, thereby improving transfection efficiency and reducing cytotoxicity.

Implementation Method 1

synthesizing the polynucleotides comprising modified nucleotides using an enzyme, or a combination thereof... self-assemble into nanoparticles with controlled size and structure through interactions between modified nucleotides

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Data Source

PatentUS10793889B2Method of packing polynucleotides
Publication Date: 2020.10.06 KOREA INST OF SCI & TECH
  • US10793889B2 patent drawing
  • US10793889B2 patent drawing
  • US10793889B2 patent drawing

AI summary

Provided is a method of preparing nanoparticle-type polynucleotides, the method comprising forming the polynucleotides comprising modified nucleotides, in which the forming includes chemically synthesizing the polynucleotides comprising modified nucleotides, synthesizing the polynucleotides comprising modified nucleotides using an enzyme, or a combination thereof.